AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2015
Dec 22, 2015
35134_dirs_2015-12-21_41671eb2-e239-4a78-899b-62eb640fe293.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2015-12-17
Reporting Person: Russell Angus C. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-17 | Non-Qualified Stock Option (right to buy) | $8.92 | A | 50000 | Acquired | 2025-12-17 | Common Stock (50000) | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16